• Zoetis Inc. Class A (ZTS $154.96)
  • $154.96 Fwd P/E: 27.82X Cap: $68.98B
  • View ZTS Profile
  • View Questions on ZTS

Q: Wondering if you think this is a good opportunity to purchase ZTS as the clear industry leader in the animal health space after missing quarterly estimates. Or is the business in decline? Is PAHC the better buy right now based on valuations and growth going forward?

Upvote 1

Read Answer Asked by Thomas on February 21, 2025

• Microsoft Corporation (MSFT $503.32)
  • $503.32 Fwd P/E: 38.93X Cap: $3.74T
  • View MSFT Profile
  • View Questions on MSFT
• Zoetis Inc. Class A (ZTS $154.96)
  • $154.96 Fwd P/E: 27.82X Cap: $68.98B
  • View ZTS Profile
  • View Questions on ZTS
• Novo Nordisk A/S (NVO $68.93)
  • $68.93 Fwd P/E: 19.74X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO

Q: I am seeking single digit capital gain over the next 2 years which of the 3 companies would you buy. and why. what is the biggest risk for ZTS. is the competition from LLY now baked in to the price ofNVO thanks Richard

Upvote 2

Read Answer Asked by richard on February 20, 2025

• Zoetis Inc. Class A (ZTS $154.96)
  • $154.96 Fwd P/E: 27.82X Cap: $68.98B
  • View ZTS Profile
  • View Questions on ZTS

Q: Why is Zoetis down $33 from peak in the last 12 months. Good time for a tax loss sale?

Upvote 2

Read Answer Asked by Cory on January 27, 2025